請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/46262
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 徐立中 | |
dc.contributor.author | Bang-Yan Yang | en |
dc.contributor.author | 楊邦彥 | zh_TW |
dc.date.accessioned | 2021-06-15T05:00:34Z | - |
dc.date.available | 2016-08-01 | |
dc.date.copyright | 2010-09-09 | |
dc.date.issued | 2010 | |
dc.date.submitted | 2010-07-28 | |
dc.identifier.citation | Akira, S., Uematsu, S., and Takeuchi, O. (2006). Pathogen recognition and innate immunity. Cell 124, 783-801.
Barbie, D.A., Tamayo, P., Boehm, J.S., Kim, S.Y., Moody, S.E., Dunn, I.F., Schinzel, A.C., Sandy, P., Meylan, E., Scholl, C., et al. (2009). Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1. Nature 462, 108-112. Bianchi, M.E. (2007). DAMPs, PAMPs and alarmins: all we need to know about danger. J Leukoc Biol 81, 1-5. Bonnard, M., Mirtsos, C., Suzuki, S., Graham, K., Huang, J., Ng, M., Itie, A., Wakeham, A., Shahinian, A., Henzel, W.J., et al. (2000). Deficiency of T2K leads to apoptotic liver degeneration and impaired NF-kappaB-dependent gene transcription. EMBO J 19, 4976-4985. Buss, H., Dorrie, A., Schmitz, M.L., Hoffmann, E., Resch, K., and Kracht, M. (2004). Constitutive and interleukin-1-inducible phosphorylation of p65 NF-{kappa}B at serine 536 is mediated by multiple protein kinases including I{kappa}B kinase (IKK)-{alpha}, IKK{beta}, IKK{epsilon}, TRAF family member-associated (TANK)-binding kinase 1 (TBK1), and an unknown kinase and couples p65 to TATA-binding protein-associated factor II31-mediated interleukin-8 transcription. J Biol Chem 279, 55633-55643. Chang, T.H., Kubota, T., Matsuoka, M., Jones, S., Bradfute, S.B., Bray, M., and Ozato, K. (2009). Ebola Zaire Virus Blocks Type I Interferon Production by Exploiting the Host SUMO Modification Machinery. Plos Pathog 5, -. Chau, T.L., Gioia, R., Gatot, J.S., Patrascu, F., Carpentier, I., Chapelle, J.P., O'Neill, L., Beyaert, R., Piette, J., and Chariot, A. (2008). Are the IKKs and IKK-related kinases TBK1 and IKK-epsilon similarly activated? Trends Biochem Sci 33, 171-180. Clement, J.F., Meloche, S., and Servant, M.J. (2008). The IKK-related kinases: from innate immunity to oncogenesis. Cell Res 18, 889-899. Creagh, E.M., and O'Neill, L.A. (2006). TLRs, NLRs and RLRs: a trinity of pathogen sensors that co-operate in innate immunity. Trends Immunol 27, 352-357. Cusson-Hermance, N., Khurana, S., Lee, T.H., Fitzgerald, K.A., and Kelliher, M.A. (2005). Rip1 mediates the Trif-dependent toll-like receptor 3- and 4-induced NF-{kappa}B activation but does not contribute to interferon regulatory factor 3 activation. J Biol Chem 280, 36560-36566. Deng, L., Wang, C., Spencer, E., Yang, L., Braun, A., You, J., Slaughter, C., Pickart, C., and Chen, Z.J. (2000). Activation of the IkappaB kinase complex by TRAF6 requires a dimeric ubiquitin-conjugating enzyme complex and a unique polyubiquitin chain. Cell 103, 351-361. Endter, C., Kzhyshkowska, J., Stauber, R., and Dobner, T. (2001). SUMO-1 modification required for transformation by adenovirus type 5 early region 1B 55-kDa oncoprotein. Proc Natl Acad Sci U S A 98, 11312-11317. Fitzgerald, K.A., McWhirter, S.M., Faia, K.L., Rowe, D.C., Latz, E., Golenbock, D.T., Coyle, A.J., Liao, S.M., and Maniatis, T. (2003). IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway. Nat Immunol 4, 491-496. Fujita, F., Taniguchi, Y., Kato, T., Narita, Y., Furuya, A., Ogawa, T., Sakurai, H., Joh, T., Itoh, M., Delhase, M., et al. (2003). Identification of NAP1, a regulatory subunit of IkappaB kinase-related kinases that potentiates NF-kappaB signaling. Mol Cell Biol 23, 7780-7793. Fukuda, I., Ito, A., Hirai, G., Nishimura, S., Kawasaki, H., Saitoh, H., Kimura, K., Sodeoka, M., and Yoshida, M. (2009). Ginkgolic acid inhibits protein SUMOylation by blocking formation of the E1-SUMO intermediate. Chem Biol 16, 133-140. Fukuzawa, T., Samaraweera, P., Mangano, F.T., Law, J.H., and Bagnara, J.T. (1995). Evidence that MIF plays a role in the development of pigmentation patterns in the frog. Dev Biol 167, 148-158. Gatot, J.S., Gioia, R., Chau, T.L., Patrascu, F., Warnier, M., Close, P., Chapelle, J.P., Muraille, E., Brown, K., Siebenlist, U., et al. (2007). Lipopolysaccharide-mediated interferon regulatory factor activation involves TBK1-IKKepsilon-dependent Lys(63)-linked polyubiquitination and phosphorylation of TANK/I-TRAF. J Biol Chem 282, 31131-31146. Ghosh, S., May, M.J., and Kopp, E.B. (1998). NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. Annu Rev Immunol 16, 225-260. Gill, G. (2004). SUMO and ubiquitin in the nucleus: different functions, similar mechanisms? Genes Dev 18, 2046-2059. Gilmore, T.D. (2006). Introduction to NF-kappaB: players, pathways, perspectives. Oncogene 25, 6680-6684. Girdwood, D., Bumpass, D., Vaughan, O.A., Thain, A., Anderson, L.A., Snowden, A.W., Garcia-Wilson, E., Perkins, N.D., and Hay, R.T. (2003). P300 transcriptional repression is mediated by SUMO modification. Mol Cell 11, 1043-1054. Gohda, J., Matsumura, T., and Inoue, J. (2004). Cutting edge: TNFR-associated factor (TRAF) 6 is essential for MyD88-dependent pathway but not toll/IL-1 receptor domain-containing adaptor-inducing IFN-beta (TRIF)-dependent pathway in TLR signaling. J Immunol 173, 2913-2917. Guo, B., and Cheng, G. (2007). Modulation of the interferon antiviral response by the TBK1/IKKi adaptor protein TANK. J Biol Chem 282, 11817-11826. Hacker, H., and Karin, M. (2006). Regulation and function of IKK and IKK-related kinases. Sci STKE 2006, re13. Han, K.J., Su, X., Xu, L.G., Bin, L.H., Zhang, J., and Shu, H.B. (2004). Mechanisms of the TRIF-induced interferon-stimulated response element and NF-kappaB activation and apoptosis pathways. J Biol Chem 279, 15652-15661. Hansson, G.K., and Libby, P. (2006). The immune response in atherosclerosis: a double-edged sword. Nat Rev Immunol 6, 508-519. Hay, R.T. (2005). SUMO: a history of modification. Mol Cell 18, 1-12. Honda, K., and Taniguchi, T. (2006). IRFs: master regulators of signalling by Toll-like receptors and cytosolic pattern-recognition receptors. Nat Rev Immunol 6, 644-658. Hsu, L.C., Park, J.M., Zhang, K., Luo, J.L., Maeda, S., Kaufman, R.J., Eckmann, L., Guiney, D.G., and Karin, M. (2004). The protein kinase PKR is required for macrophage apoptosis after activation of Toll-like receptor 4. Nature 428, 341-345. Ikeda, F., Hecker, C.M., Rozenknop, A., Nordmeier, R.D., Rogov, V., Hofmann, K., Akira, S., Dotsch, V., and Dikic, I. (2007). Involvement of the ubiquitin-like domain of TBK1/IKK-i kinases in regulation of IFN-inducible genes. EMBO J 26, 3451-3462. Ishov, A.M., Sotnikov, A.G., Negorev, D., Vladimirova, O.V., Neff, N., Kamitani, T., Yeh, E.T., Strauss, J.F., 3rd, and Maul, G.G. (1999). PML is critical for ND10 formation and recruits the PML-interacting protein daxx to this nuclear structure when modified by SUMO-1. J Cell Biol 147, 221-234. James, P., Halladay, J., and Craig, E.A. (1996). Genomic libraries and a host strain designed for highly efficient two-hybrid selection in yeast. Genetics 144, 1425-1436. Jiang, Z., Mak, T.W., Sen, G., and Li, X. (2004). Toll-like receptor 3-mediated activation of NF-kappaB and IRF3 diverges at Toll-IL-1 receptor domain-containing adapter inducing IFN-beta. Proc Natl Acad Sci U S A 101, 3533-3538. Karin, M., and Greten, F.R. (2005). NF-kappaB: linking inflammation and immunity to cancer development and progression. Nat Rev Immunol 5, 749-759. Kawai, T., and Akira, S. (2007). Signaling to NF-kappaB by Toll-like receptors. Trends Mol Med 13, 460-469. Kim, K.I., Baek, S.H., and Chung, C.H. (2002). Versatile protein tag, SUMO: its enzymology and biological function. J Cell Physiol 191, 257-268. Kirsh, O., Seeler, J.S., Pichler, A., Gast, A., Muller, S., Miska, E., Mathieu, M., Harel-Bellan, A., Kouzarides, T., Melchior, F., et al. (2002). The SUMO E3 ligase RanBP2 promotes modification of the HDAC4 deacetylase. EMBO J 21, 2682-2691. Kubota, T., Matsuoka, M., Chang, T.H., Tailor, P., Sasaki, T., Tashiro, M., Kato, A., and Ozato, K. (2008). Virus infection triggers SUMOylation of IRF3 and IRF7, leading to the negative regulation of type I interferon gene expression. Journal of Biological Chemistry 283, 25660-25670. Landstrom, M. (2010). The TAK1-TRAF6 signalling pathway. Int J Biochem Cell Biol 42, 585-589. Lemaitre, B. (2004). The road to Toll. Nat Rev Immunol 4, 521-527. Lemaitre, B., Nicolas, E., Michaut, L., Reichhart, J.M., and Hoffmann, J.A. (1996). The dorsoventral regulatory gene cassette spatzle/Toll/cactus controls the potent antifungal response in Drosophila adults. Cell 86, 973-983. Leulier, F., and Lemaitre, B. (2008). Toll-like receptors--taking an evolutionary approach. Nat Rev Genet 9, 165-178. Liew, F.Y., Xu, D., Brint, E.K., and O'Neill, L.A. (2005). Negative regulation of toll-like receptor-mediated immune responses. Nat Rev Immunol 5, 446-458. Lin, W.W., and Karin, M. (2007). A cytokine-mediated link between innate immunity, inflammation, and cancer. J Clin Invest 117, 1175-1183. Liu, Z.H., Chen, J., Yu, L.S., Jiang, H.D., Yao, T.W., and Zeng, S. (2009). Structural elucidation of metabolites of ginkgolic acid in rat liver microsomes by ultra-performance liquid chromatography/electrospray ionization tandem mass spectrometry and hydrogen/deuterium exchange. Rapid Commun Mass Spectrom 23, 1899-1906. Lu, Y.C., Yeh, W.C., and Ohashi, P.S. (2008). LPS/TLR4 signal transduction pathway. Cytokine 42, 145-151. Mabb, A.M., and Miyamoto, S. (2007). SUMO and NF-kappaB ties. Cell Mol Life Sci 64, 1979-1996. McWhirter, S.M., Fitzgerald, K.A., Rosains, J., Rowe, D.C., Golenbock, D.T., and Maniatis, T. (2004). IFN-regulatory factor 3-dependent gene expression is defective in Tbk1-deficient mouse embryonic fibroblasts. Proc Natl Acad Sci U S A 101, 233-238. Medzhitov, R. (2007). Recognition of microorganisms and activation of the immune response. Nature 449, 819-826. Medzhitov, R. (2008). Origin and physiological roles of inflammation. Nature 454, 428-435. Melchior, F. (2000). SUMO--nonclassical ubiquitin. Annu Rev Cell Dev Biol 16, 591-626. Meylan, E., Burns, K., Hofmann, K., Blancheteau, V., Martinon, F., Kelliher, M., and Tschopp, J. (2004). RIP1 is an essential mediator of Toll-like receptor 3-induced NF-kappa B activation. Nat Immunol 5, 503-507. Muller, S., Ledl, A., and Schmidt, D. (2004). SUMO: a regulator of gene expression and genome integrity. Oncogene 23, 1998-2008. Nomura, F., Kawai, T., Nakanishi, K., and Akira, S. (2000). NF-kappaB activation through IKK-i-dependent I-TRAF/TANK phosphorylation. Genes Cells 5, 191-202. O'Neill, L.A. (2008). When signaling pathways collide: positive and negative regulation of toll-like receptor signal transduction. Immunity 29, 12-20. O'Neill, L.A., and Bowie, A.G. (2007). The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling. Nat Rev Immunol 7, 353-364. O'Neill, L.A., Dunne, A., Edjeback, M., Gray, P., Jefferies, C., and Wietek, C. (2003). Mal and MyD88: adapter proteins involved in signal transduction by Toll-like receptors. J Endotoxin Res 9, 55-59. Pascual, G., Fong, A.L., Ogawa, S., Gamliel, A., Li, A.C., Perissi, V., Rose, D.W., Willson, T.M., Rosenfeld, M.G., and Glass, C.K. (2005). A SUMOylation-dependent pathway mediates transrepression of inflammatory response genes by PPAR-gamma. Nature 437, 759-763. Pichler, A., Gast, A., Seeler, J.S., Dejean, A., and Melchior, F. (2002). The nucleoporin RanBP2 has SUMO1 E3 ligase activity. Cell 108, 109-120. Pichler, A., Knipscheer, P., Saitoh, H., Sixma, T.K., and Melchior, F. (2004). The RanBP2 SUMO E3 ligase is neither HECT- nor RING-type. Nat Struct Mol Biol 11, 984-991. Pomerantz, J.L., and Baltimore, D. (1999). NF-kappaB activation by a signaling complex containing TRAF2, TANK and TBK1, a novel IKK-related kinase. EMBO J 18, 6694-6704. Rebsamen, M., Meylan, E., Curran, J., and Tschopp, J. (2008). The antiviral adaptor proteins Cardif and Trif are processed and inactivated by caspases. Cell Death Differ 15, 1804-1811. Ribet, D., Hamon, M., Gouin, E., Nahori, M.A., Impens, F., Neyret-Kahn, H., Gevaert, K., Vandekerckhove, J., Dejean, A., and Cossart, P. (2010). Listeria monocytogenes impairs SUMOylation for efficient infection. Nature 464, 1192-U1111. Ryzhakov, G., and Randow, F. (2007). SINTBAD, a novel component of innate antiviral immunity, shares a TBK1-binding domain with NAP1 and TANK. EMBO J 26, 3180-3190. Sachdev, S., Bruhn, L., Sieber, H., Pichler, A., Melchior, F., and Grosschedl, R. (2001). PIASy, a nuclear matrix-associated SUMO E3 ligase, represses LEF1 activity by sequestration into nuclear bodies. Genes Dev 15, 3088-3103. Saitoh, H. (1999). [The role of ubiquitin-like protein SUMO-1 in the nucleus]. Tanpakushitsu Kakusan Koso 44, 1852-1859. Saitoh, N., Uchimura, Y., Tachibana, T., Sugahara, S., Saitoh, H., and Nakao, M. (2006). In situ SUMOylation analysis reveals a modulatory role of RanBP2 in the nuclear rim and PML bodies. Exp Cell Res 312, 1418-1430. Seeler, J.S., Marchio, A., Losson, R., Desterro, J.M., Hay, R.T., Chambon, P., and Dejean, A. (2001). Common properties of nuclear body protein SP100 and TIF1alpha chromatin factor: role of SUMO modification. Mol Cell Biol 21, 3314-3324. Sha, W.C. (1998). Regulation of immune responses by NF-kappa B/Rel transcription factor. J Exp Med 187, 143-146. Sharma, S., tenOever, B.R., Grandvaux, N., Zhou, G.P., Lin, R., and Hiscott, J. (2003). Triggering the interferon antiviral response through an IKK-related pathway. Science 300, 1148-1151. Shim, J.H., Xiao, C., Paschal, A.E., Bailey, S.T., Rao, P., Hayden, M.S., Lee, K.Y., Bussey, C., Steckel, M., Tanaka, N., et al. (2005). TAK1, but not TAB1 or TAB2, plays an essential role in multiple signaling pathways in vivo. Genes Dev 19, 2668-2681. Shimada, T., Kawai, T., Takeda, K., Matsumoto, M., Inoue, J., Tatsumi, Y., Kanamaru, A., and Akira, S. (1999). IKK-i, a novel lipopolysaccharide-inducible kinase that is related to IkappaB kinases. Int Immunol 11, 1357-1362. Sil, A.K., Maeda, S., Sano, Y., Roop, D.R., and Karin, M. (2004). IkappaB kinase-alpha acts in the epidermis to control skeletal and craniofacial morphogenesis. Nature 428, 660-664. Swaminathan, S., Kiendl, F., Korner, R., Lupetti, R., Hengst, L., and Melchior, F. (2004). RanGAP1*SUMO1 is phosphorylated at the onset of mitosis and remains associated with RanBP2 upon NPC disassembly. J Cell Biol 164, 965-971. Tojima, Y., Fujimoto, A., Delhase, M., Chen, Y., Hatakeyama, S., Nakayama, K., Kaneko, Y., Nimura, Y., Motoyama, N., Ikeda, K., et al. (2000). NAK is an IkappaB kinase-activating kinase. Nature 404, 778-782. Trinchieri, G., and Sher, A. (2007). Cooperation of Toll-like receptor signals in innate immune defence. Nat Rev Immunol 7, 179-190. Viatour, P., Merville, M.P., Bours, V., and Chariot, A. (2005). Phosphorylation of NF-kappaB and IkappaB proteins: implications in cancer and inflammation. Trends Biochem Sci 30, 43-52. West, A.P., Koblansky, A.A., and Ghosh, S. (2006). Recognition and signaling by toll-like receptors. Annu Rev Cell Dev Biol 22, 409-437. Willment, J.A., and Brown, G.D. (2008). C-type lectin receptors in antifungal immunity. Trends Microbiol 16, 27-32. Yamamoto, M., Sato, S., Hemmi, H., Hoshino, K., Kaisho, T., Sanjo, H., Takeuchi, O., Sugiyama, M., Okabe, M., Takeda, K., et al. (2003). Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway. Science 301, 640-643. Yang, S.H., Galanis, A., Witty, J., and Sharrocks, A.D. (2006). An extended consensus motif enhances the specificity of substrate modification by SUMO. EMBO J 25, 5083-5093. | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/46262 | - |
dc.description.abstract | Toll like receptors (TLRs) 訊息傳遞所產生的前發炎細胞激素(pro-inflammatory cytokines)以及第一型干擾素(type I interferon)對於宿主的先天性免疫(innate immunity)扮演非常重要的角色。而TLRs 受器主要是透過辨識一些病原菌相關的物質來啟動其訊息傳遞,而這些病原菌相關的物質又被稱為PAMPs (pathogen-associated molecular patterns)。TLRs的訊息主要是透過兩個含有 TIR domain的轉接蛋白傳遞,包括MyD88 及 TRIF。其中,MyD88 已經知道對於典型的NF-κB (canonical NF-κB)活化以及前發炎細胞激素的生成扮演關鍵性角色;而另一方面;在TRIF所引導的訊息傳遞當中,由過去的一些研究,已經了解TRIF可以徵招TBK1進而調控第一型干擾素的生成。此外,許多研究也指出,TRIF也參與在調控NF-κB 相關基因的表現,但是詳細的機制到目前為止並不明瞭。 在TBK1的研究中,已經知道TBK1屬於IKK 激脢 (kinase) 家族的一員,長久以來, TBK1 被認為在調控第一型干擾素的生成以及先天性免疫的訊息傳遞中是必要的。但是,TBK1在先天性免疫訊息傳遞中的其他功能尚未明瞭。
為了解TBK1在TLR 訊息傳遞中是否具有其他功能,我們使用LPS或是 poly I:C刺激巨噬細胞(Macrophages)並發現到TBK1會被進一步活化,同時我們也發現TBK1對於NF-κB活性是非常重要的。另一方面,我們也透過酵母雙雜交系統( yeast-two-hybrid screening)找到了新的TBK結合蛋白。而且在我們的實驗當中,我們證實,在LPS 刺激之後,TBK1會與與此蛋白質結合並可能進一步的調控TBK1的後轉譯修飾並進一步活化NF-κB活性。以上的實驗結果說明: 受LPS或poly I:C 活化後, TBK1對於調控巨噬細胞的NF-κB活化和部分NF-κB相關基因表現,扮演關鍵性的角色。這個研究也提供新的觀點讓我們能夠更深入去了解TLR的訊息傳遞以及其調控機制。 | zh_TW |
dc.description.abstract | Toll like receptors (TLRs) is of central importance for providing the first line of host defense, and controlling the initiation and determination of the adaptive immune response. TLRs initiate the signal transduction through sensing variety pathogen derived molecules terms PAMPs (pathogen-associated molecular patterns). The signals are transmitted by two major TIR containing adaptors, MyD88 and TRIF. It has been suggested that MyD88 is crucial for canonical NF-κB activation and pro-inflammatory cytokine induction, whereas TRIF is important for TBK1 activation and upregulation of type I interferon responsive genes. Recently, TRIF-signaling has been shown to be indispensable for expressions of NF-κB-mediated genes, but the molecular mechanism is still elusive. TBK1/NAK is a serine/threonine kinase that belongs to the IkB kinase (IKK) family. TBK1 has long been recognized as a key kinase required for production of type I interferon and interferone-responsive genes in many innate immune signaling, but not much is known about its other physiological functions.
In this study, we uncovered a novel function of TBK1 in TLR3/4 signalings. Our data demonstrated that LPS or polyIC is able to induce TBK1 activation and then modulate NF-κB activity. In addition, we identified a new TBK1-interacting protein by using the yeast-two hybrid screening. The novel TBK1-interacting protein associates with TBK1 and processes post-translational modification after LPS stimulation. Taken together, our findings reveal that LPS- or polyIC- induce TBK1 activation which is required for NF-κB activity and production of some, if not all, NF-κB-mediated genes in macrophages. This study should provide new insights to the TLR signaling and its regulation. | en |
dc.description.provenance | Made available in DSpace on 2021-06-15T05:00:34Z (GMT). No. of bitstreams: 1 ntu-99-R97448011-1.pdf: 2138912 bytes, checksum: 3b6db966c828548b988af84590c873a1 (MD5) Previous issue date: 2010 | en |
dc.description.tableofcontents | 致謝................................................................................................................................1
摘要………………………………………… …………………….………………..2 Abstract……………………………………………………………………………4 Contents……………………………………………………………………………6 Introduction…………………………………………………………...…………...10 TLRs signaling pathways: TIR domain containing adaptors……………………………………12 MyD88-dependent signaling…………………………………………13 TRIF-dependent pathway……………………………………………….15 NF-κB activation in TLR signaling……………………………………17 IKK-related kinases: TBK1 and IKKi………………………………..18 The Sumoylation machinery……………………………………………………20 Sumoylation in innate immunity………………………………………………..23 Specific aims……………………………………………………………………24 Materals and Methods……………………………………………………………25 Reagent……………………………………………………………………….25 Plasmid………………………………………………………………………..26 Cell culture and transfection…………………………………………………27 Bone marrow derived macrophage (BMDM) culture…………………………28 Generation of Tbk1-silenced Raw264.7 cells…………………………………29 Preparation of whole cell lysates…………………………………………….29 Nuclear and cytosolic extract fractionation……………………………………30 Immunoblotting……………………………………………………………….30 Immunoprecipitation…………………………………………………………31 GST protein purification……………………………………………………….32 In vitro kinase Assay……………………………………………………………33 Total RNA extraction………………………………………………………….34 Real-Time Quantitative PCR (RT-QPCR)………………………………………34 Immunofluorescence staining………………………………………………….35 Chromatin immunoprecipitation (ChIP) assay………………………………….36 Luciferase assay………………………………………………………………...38 Yeast two-hybrid screening……………………………………………………..38 Statistical analysis……………………………………………………………40 Result………………………………………………………………………………41 1. Deficiency of TBK1 impaired expression of NF-κB regulated genes in LPS-induced macrophages…………………………………………………….41 2. Tbk1 deficiency impaired phosphrylation of p65 at Ser536……………………..42 3. TBK1 phosphorylated p65 at Serine 536 after TLR4 engagement………………43 4. A conserved NLS in the kinase domain of TBK1 is essential for its nuclear translocation ……………………………………………………………………45 5. Nuclear TBK1 is required for NF-κB activation……………………………….46 6. TBK1 mediates p65 binding to the promoter of NF-κB regulated gene……….46 7. RanBP2 mediated TBK1 sumoylation in response to LPS…………………….47 Discussion…………………………………………………………………………51 Figure……………………………………………………………………………..62 Figure 1………………………………………………………………………62 Figure 2..…………………………………………………………………64 Figure 3……………………………………………………………………65 Figure 4…………………………………………………………………..69 Figure 5…………………………………………………………………..72 Figure 6…………………………………………………………………..73 Figure 7……………………………………………………………………74 Figure 8…………………………………………………………………..75 Figure 9………………………………………………………………….76 Figure 10………………………………………………………………….78 Figure 11………………………………………………………………….80 Table……………………………………………………………………………81 Table 1……………………………………………………………………81 Supplementary figure………………………………………………………….82 Supplementary figure 1..………………………………………………….82 Supplementary figure 2……………………………………………………83 Supplementary figure 3……………………………………………………84 Supplementary figure 4…………………………………………………….85 Reference…………………………………………………………………………86 | |
dc.language.iso | en | |
dc.title | TBK1 在 TLR3/4訊息傳遞中扮演之角色 | zh_TW |
dc.title | The functional roles of TBK1 in TLR3/4 signalings | en |
dc.type | Thesis | |
dc.date.schoolyear | 98-2 | |
dc.description.degree | 碩士 | |
dc.contributor.oralexamcommittee | 呂勝春,伍安怡,蕭信宏 | |
dc.subject.keyword | TLR訊息傳遞, | zh_TW |
dc.subject.keyword | TBK1, TLR3, TLR4, | en |
dc.relation.page | 94 | |
dc.rights.note | 有償授權 | |
dc.date.accepted | 2010-07-28 | |
dc.contributor.author-college | 醫學院 | zh_TW |
dc.contributor.author-dept | 分子醫學研究所 | zh_TW |
顯示於系所單位: | 分子醫學研究所 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-99-1.pdf 目前未授權公開取用 | 2.09 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。